Tumor 'Mini-Me' tested to match cancer drugs to patients
NCT ID NCT06686979
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study looks at whether growing a patient's tumor cells in the lab (called organoids) and testing drugs on them can predict how well those drugs will work in the patient. It involves 40 people with recurrent or metastatic salivary gland cancer. Researchers will compare the lab test results to the actual response from standard treatment, but the lab results will not be used to change treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could show that testing drugs on a patient's tumor cells in a dish helps doctors choose the right treatment, making therapy more personalized.
- What could go wrong
- This is a small, early observational study (40 people) that only checks if lab results match real-world outcomes. It does not test a new treatment, so it may not directly improve care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRUG SENSITIVE TEST IN VITRO are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Huashan Hospital, Fudan University
ACTIVE_NOT_RECRUITINGShanghai, Shanghai Municipality, 200040, China
-
Huashan Hospital, Fudan University
RECRUITINGShanghai, Shanghai Municipality, 200040, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.